Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation Research

• Publication date

  2014-03-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.114.303454PMID 24647144PMCID PMC4076170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Legionella Kinase LegK2 Targets the ARP2/3 Complex To Inhibit Actin Nucleation on Phagosomes and Allow Bacterial Evasion of the Late Endocytic Pathway

  2015cited by this paper
• Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases.

  2012cited by this paper
• The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.

  2012cited by this paper
• Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions*

  2012cited by this paper
• Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

  2011influential reference
• The acute phase response inhibits reverse cholesterol transport1

  2010cited by this paper
• Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein.

  2010cited by this paper
• Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export1

  2010cited by this paper
• The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

  2010cited by this paper
• Inflammation Impairs Reverse Cholesterol Transport In Vivo

  2009cited by this paper
• Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I

  2008cited by this paper
• Identification of Proteins Adducted by Lipid Peroxidation Products in Plasma and Modifications of Apolipoprotein A1 with a Novel Biotinylated Phospholipid Probe

  2008cited by this paper
• Apolipoprotein A-I Tryptophan Substitution Leads to Resistance to Myeloperoxidase-Mediated Loss of Function

  2008cited by this paper
• Increased methionine sulfoxide content of apoA-I in type 1 diabetes Published, JLR Papers in Press, January 17, 2008.

  2008cited by this paper
• The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

  2008cited by this paper
• Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high-density lipoprotein oxidized by myeloperoxidase.

  2008cited by this paper
• HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.

  2008cited by this paper
• Molecular regulation of macrophage reverse cholesterol transport

  2007cited by this paper
• The Structure of Apolipoprotein A-I in High Density Lipoproteins*

  2007cited by this paper
• Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I*

  2006cited by this paper
• Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins*

  2006cited by this paper
• ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease.

  2005cited by this paper
• Tyrosine 192 in Apolipoprotein A-I Is the Major Site of Nitration and Chlorination by Myeloperoxidase, but Only Chlorination Markedly Impairs ABCA1-dependent Cholesterol Transport*

  2005cited by this paper
• Role of oxidative modifications in atherosclerosis.

  2004cited by this paper
• The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

  2004cited by this paper
• Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

  2004cited by this paper
• Antiinflammatory Properties of HDL

  2004cited by this paper
• Optimized bacterial expression of human apolipoprotein A-I.

  2003cited by this paper
• ATVB In Focus Role of ABCA1 in Cellular Cholesterol Efflux and Reverse Cholesterol Transport

  2003cited by this paper
• Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues

  2002cited by this paper
• Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis

  2001cited by this paper
• Oxidation of Methionine Residues to Methionine Sulfoxides Does Not Decrease Potential Antiatherogenic Properties of Apolipoprotein A-I*

  2000cited by this paper
• Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

  2000cited by this paper
• Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase.

  2000cited by this paper
• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.

  1999cited by this paper
• Effluxed lipids: Tangier Island's latest export.

  1999cited by this paper
• Oxidation of High Density Lipoproteins

  1998cited by this paper
• The role of oxidized lipoproteins in atherogenesis.

  1996cited by this paper
• Human neutrophils employ chlorine gas as an oxidant during phagocytosis.

  1996cited by this paper
• Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization.

  1995cited by this paper
• Chlorination of Tyrosyl Residues in Peptides by Myeloperoxidase and Human Neutrophils (*)

  1995cited by this paper
• Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

  1995cited by this paper
• Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

  1995cited by this paper
• Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

  1994cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• The cornea in familial high density lipoprotein deficiency, tangier disease

  1991cited by this paper
• High-density lipoprotein--the clinical implications of recent studies.

  1989cited by this paper
• Leukocytic oxygen activation and microbicidal oxidative toxins.

  1989cited by this paper
• Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite.

  1985cited by this paper
• A Light and Electron Microscopic Study

  1976cited by this paper
• The pathology of Tangier disease. A light and electron microscopic study.

  1975cited by this paper
• Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments

  year unknowncited by this paper

• Insights to HDL dysfunctionality: hypothesis of exhausted HDL.

  2026cites this paper
• ApoA-I dissociated from human HDL retains its acceptor properties in ABCA1-mediated cholesterol efflux from RAW 264.7 macrophages in coronary artery disease

  2025cites this paper
• In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligands

  2025cites this paper
• A critical review on technical advances and multifaceted role of carotenoids in human health with special emphasis on metabolic diseases

  2025cites this paper
• Itaconate alleviates cholesterol burden via ABCA1 stabilization and cholesterol efflux.

  2025cites this paper
• Repurposing Bacopa monnieri extracts containing Aquaporin-1 blockers to improve systemic oxidative stress: the BacOxy_I study

  2025cites this paper
• Stratified analysis of carotid plaque and intima–media thickness as stroke predictors in type 2 diabetes

  2025cites this paper
• The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The New Progress

  2024cites this paper
• Enhancement of Intracellular Cholesterol Efflux in Chondrocytes Leading to Alleviation of Osteoarthritis Progression

  2024cites this paper
• TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis

  2024cites this paper
• Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction

  2024cites this paper
• The Effects of Adlay Tea Intake on Immune Homeostasis and Vascular Endothelial Function in Healthy Adults: A Randomized, Double-Blind, Parallel-Group Comparative Study.

  2024cites this paper
• Myeloperoxidase and its derivative hypochlorous acid combined clinical indicators predict new-onset atrial fibrillation in sepsis: a case-control study

  2024cites this paper
• Association of pro-inflammatory cytokines, inflammatory proteins with atherosclerosis index in obese male subjects

  2023cites this paper
• High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p

  2023cites this paper
• Dyslipidemia in patients with Multiple Sclerosis and its correlation with disease parameters

  2023cites this paper
• High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA

  2023cites this paper
• The association between high-density lipoproteins and periodontitis.

  2023cites this paper
• Biomarkers of Cardiovascular Disease and Future Directions: A Review

  2023cites this paper
• Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients

  2023cites this paper
• Age-Related Diseases and Foods Generating Chlorinative Stress

  2023cites this paper
• HDL cholesterol efflux capacity and phospholipid content are associated with the severity of acute ischemic stroke and predict its outcome.

  2023cites this paper
• 10,12-Conjugated linoleic acid supplementation improves HDL composition and function in mice

  2022cites this paper
• Vascular dysfunction and dyslipidemia in multiple sclerosis: are they correlated with disease duration and disability status?

  2022cites this paper
• Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis

  2022cites this paper
• Using adenovirus-mediated gene transfer to study the effect of myeloperoxidase on plasma lipid levels, HDL structure and functionality in mice expressing human apoA-I forms.

  2022cites this paper
• HDL and Oxidation.

  2022cites this paper
• Remembering your A, B, C's: Alzheimer's disease and ABCA1

  2022cites this paper
• Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes

  2022cites this paper
• Cholesterol Efflux and Macrophage Polarization in Human Adipose Tissue.

  2022cites this paper
• High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis

  2022cites this paper
• Cholesterol Efflux and Collateral Circulation in Chronic Total Coronary Occlusion: Effect‐Circ Study

  2021cites this paper
• Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development

  2021cites this paper
• Myeloperoxidase Targets Apolipoprotein A-I for Site-Specific Tyrosine Chlorination in Atherosclerotic Lesions and Generates Dysfunctional High-Density Lipoprotein.

  2021cites this paper
• Functional Food and Bioactive Compounds on the Modulation of the Functionality of HDL-C: A Narrative Review

  2021cites this paper
• Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness

  2021cites this paper
• Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations

  2021cites this paper
• Changing Perspectives on HDL: From Simple Quantity Measurements to Functional Quality Assessment

  2021cites this paper
• Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis

  2021cites this paper
• High-sensitivity CRP may be a marker of HDL dysfunction and remodeling in patients with acute coronary syndrome

  2021cites this paper
• Cross-Sectional Associations Between HDL Structure or Function, Cell Membrane Fatty Acid Composition, and Inflammation in Elderly Adults.

  2021cites this paper
• Oxidative Posttranslational Modifications of Blood Plasma Proteins of Cosmonauts after a Long-Term Flight: Part II

  2021cites this paper
• MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High‐Density Lipoprotein, and Low‐Density Lipoprotein Receptor–Mediated Reverse Cholesterol Transport

  2021cites this paper
• The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation

  2021cites this paper
• Antioxidant and Anti-inflammatory Mechanisms of Astaxanthin in Cardiovascular Diseases

  2020cites this paper
• Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting.

  2020cites this paper
• Angiogenic and Antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients

  2020cites this paper
• Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity

  2020cites this paper
• Recent Advances in the Molecular Imaging of Atherosclerosis

  2020cites this paper
• Cholesterol efflux capacity in coronary artery disease: a meta-analysis

  2020cites this paper
• LOX-1: A potential driver of cardiovascular risk in SLE patients

  2020cites this paper
• Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis

  2020cites this paper
• Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice

  2020cites this paper
• Fibrillar conformation of an apolipoprotein A-I variant involved in amyloidosis and atherosclerosis.

  2020cites this paper
• High-Sensitivity CRP is Independently Associated with HDL-Mediated Cholesterol Efflux Capacity and HDL Remodeling in Patients with Coronary Artery Disease

  2020influential citation
• Cholesterol Absorption

  2020cites this paper
• Metabolic syndrome components and acute pancreatitis: a case–control study in China

  2020cites this paper
• Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes.

  2020cites this paper
• Antioxidant and anti-inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review)

  2020cites this paper
• Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule

  2019cites this paper
• Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage.

  2019cites this paper
• Progress in Research on Nonalcoholic Fatty Liver and Gestational Diabetes

  2019cites this paper
• APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm

  2019cites this paper
• Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Preserves HDL Atheroprotective Functions

  2019cites this paper
• Biological Consequences of Dysfunctional HDL.

  2019cites this paper
• Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression

  2019cites this paper
• Assessment of HDL Cholesterol Removal Capacity: Toward Clinical Application

  2019cites this paper
• The CSL112–2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A‐I [human]), an intravenous formulation of plasma‐derived apolipoprotein A‐I, among subjects with moderate renal impairment after acute myocardial infarction

  2019cites this paper
• Roles of cholesterol efflux capacity in the occurrence and prognosis coronary artery disease

  2019cites this paper
• HDL-Targeted Therapies During Myocardial Infarction

  2019cites this paper
• Ambient Air Pollution Is Associated With HDL (High-Density Lipoprotein) Dysfunction in Healthy Adults

  2019cites this paper
• Haptoglobin Phenotype Is Associated With High-Density Lipoprotein–Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery Disease

  2019cites this paper
• Interaction between an ATP-Binding Cassette A1 (ABCA1) Variant and Egg Consumption for the Risk of Ischemic Stroke and Carotid Atherosclerosis: a Family-Based Study in the Chinese Population

  2019cites this paper
• Modified lipoproteins in periodontitis: a link to cardiovascular disease?

  2019cites this paper
• Most Promising Therapies in Interventional Cardiology

  2019cites this paper
• Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.

  2019cites this paper
• Associations of low HDL cholesterol level and premature coronary heart disease with functionality and phospholipid composition of HDL and with plasma oxLDL antibody levels

  2019cites this paper
• Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity.

  2019cites this paper
• University of Southern Denmark Analysis of protein chlorination by mass spectrometry

  2019cites this paper
• Increased apolipoprotein C 3 drives cardiovascular risk in type 1 diabetes

  2019cites this paper
• Protein Modifications and Lifestyle Disorders

  2019cites this paper
• Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction.

  2019cites this paper
• Myeloperoxidase-Induced Oxidation of Albumin and Ceruloplasmin: Role of Tyrosines

  2019cites this paper
• Analysis of protein chlorination by mass spectrometry

  2019cites this paper
• Aggregate Polymorphism in Protein Deposition Diseases: Investigations by Magic Angle Spinning Solid State NMR and Transmission Electron Microscopy

  2019cites this paper
• Discussion on the Effectiveness of Elevating HDL-C in Treating Cardiovascular Diseases of Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients

  2018cites this paper
• A short-term increase in dietary cholesterol and fat intake affects high-density lipoprotein composition in healthy subjects.

  2018cites this paper
• High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

  2018cites this paper
• HDLs and the pathogenesis of atherosclerosis

  2018cites this paper
• Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease

  2018cites this paper
• Quercetin induces the selective uptake of HDL-cholesterol via promoting SR-BI expression and the activation of the PPARγ/LXRα pathway.

  2018cites this paper
• CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction

  2018cites this paper
• HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction.

  2018cites this paper
• Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque

  2018cites this paper
• Methionine oxidized apolipoprotein A‐I at the crossroads of HDL biogenesis and amyloid formation

  2018cites this paper
• From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.

  2018cites this paper
• The High Density Lipoprotein Cholesterol Hypothesis Revisited

  2018influential citation
• Proteomic Profiles of Young Adults with Acute Myocardial Infarction

  2018cites this paper
• Anti‐ApoA‐I IgG antibodies are not associated with carotid artery disease progression and first‐time cardiovascular events in middle‐aged individuals

  2018cites this paper